Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 2
2004 4
2005 2
2007 1
2008 1
2009 3
2010 3
2011 3
2012 3
2013 2
2014 4
2016 6
2017 2
2018 2
2019 1
2020 3
2021 4
2022 18
2023 19
2024 19
2025 20
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.
De Novellis D, Derudas D, Vincelli D, Fontana R, Della Pepa R, Palmieri S, Accardi F, Rotondo F, Morelli E, Gigliotta E, Roccotelli D, Marano L, Barone ML, Cetani G, Esposito D, Lazzaro A, Delle Cave G, Serio B, Morini D, Porrazzo M, Urciuoli E, Masucci C, Fanelli F, Rizzo M, Arcamone M, Trastulli F, Rocco S, Leone A, Bianco R, Salvatore F, Idato A, Sicari M, Tosi P, Rascato MG, Di Perna M, Falcone AP, Morello L, Carlisi M, Svanera G, Annunziata M, Frigeri F, Califano C, Carella AM, Marcacci G, Pane F, Risitano AM, Giudice V, Botta C, Selleri C. De Novellis D, et al. Among authors: serio b. Eur J Haematol. 2025 Jan;114(1):105-114. doi: 10.1111/ejh.14314. Epub 2024 Oct 6. Eur J Haematol. 2025. PMID: 39370303 Free PMC article.
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Leotta S, Markovic U, Duminuco A, Mulè A, Porretto F, Federico V, Gentile M, Pastore D, Nigro LL, Selleri C, Serio B, Calafiore V, Patti C, Mauro E, Vetro C, Maugeri C, Parisi M, Fiumara P, Parrinello L, Marino S, Scuderi G, Garibaldi B, Musso M, Renzo ND, Vigna E, Martino EA, Raimondo FD, Milone G. Leotta S, et al. Among authors: serio b. Ann Hematol. 2024 Sep;103(9):3701-3712. doi: 10.1007/s00277-024-05725-9. Epub 2024 Apr 13. Ann Hematol. 2024. PMID: 38609726
Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.
Martorelli MC, Pugliese N, Di Perna M, De Novellis D, Lombardi A, De Fazio L, Loglisci G, Peluso I, Molica M, Copia C, Ricco A, Bruzzese A, Mendicino F, De Fazio V, Santeramo TM, Bianco R, Monaco G, Fontana R, Guariglia R, Serio B, Luponio S, Della Corte AM, Malandrini A, Giudice V, Frigeri F, Tarantini G, Guarini A, Gentile M, Musto P, Annunziata M, Di Renzo N, Rossi M, Califano C, Pane F, Selleri C. Martorelli MC, et al. Among authors: serio b. Eur J Haematol. 2026 Jan;116(1):23-30. doi: 10.1111/ejh.70034. Epub 2025 Sep 16. Eur J Haematol. 2026. PMID: 40955124 Free PMC article.
Translational Research on Azacitidine Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QOL-ONE Trans-2).
Oliva EN, Cuzzola M, Porta MD, Candoni A, Salutari P, Palumbo GA, Reda G, Iannì G, Zampini M, D'Amico S, Tripepi G, Capelli D, Alati C, Cannatà MC, Niscola P, Serio B, Barillà S, Musto P, Vigna E, Melillo LMA, Tripepi R, Zannier ME, Nannya Y, Ogawa S, Mammì C. Oliva EN, et al. Among authors: serio b. Int J Mol Sci. 2024 Oct 30;25(21):11646. doi: 10.3390/ijms252111646. Int J Mol Sci. 2024. PMID: 39519198 Free PMC article. Clinical Trial.
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.
Marconi G, Piciocchi A, Audisio E, Papayannidis C, Cerrano M, Minotti C, Paoloni F, Guolo F, Bocchia M, Rondoni M, Lico A, Carrabba MG, Della Porta MG, Frigeni M, Giaccone L, Beltrami G, Cattaneo C, Di Chio MC, Serio B, Crea E, Freilone R, Capria S, Curti A, Minetto P, la Sala E, Nanni J, Zannetti BA, Simonetti G, Bochicchio MT, Saglio G, Lemoli RM, Venditti A, Vignetti M, Fazi P, Martinelli G. Marconi G, et al. Among authors: serio b. Blood Adv. 2025 May 27;9(10):2542-2552. doi: 10.1182/bloodadvances.2024014901. Blood Adv. 2025. PMID: 40048742 Free PMC article. Clinical Trial.
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve.
Visco V, Izzo C, Mancusi C, Rispoli A, Tedeschi M, Virtuoso N, Giano A, Gioia R, Melfi A, Serio B, Rusciano MR, Di Pietro P, Bramanti A, Galasso G, D'Angelo G, Carrizzo A, Vecchione C, Ciccarelli M. Visco V, et al. Among authors: serio b. J Cardiovasc Dev Dis. 2023 Feb 9;10(2):74. doi: 10.3390/jcdd10020074. J Cardiovasc Dev Dis. 2023. PMID: 36826570 Free PMC article. Review.
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.
Nanni J, Azzali I, Papayannidis C, Mulè A, Audisio E, Martelli MP, Scappini B, Chiusolo P, Cambò B, Candoni A, Lunghi M, Albano F, Olivieri A, Fracchiolla N, Bernardi M, Romani C, Rigolin GM, Giannini MB, Bocchia M, Todisco E, Cilloni D, Bochicchio MT, Ottaviani E, Mattei A, Zamagni F, Valli I, Volpi R, Marconi G, Petracci E; FLAM Collaborative Group; Martinelli G. Nanni J, et al. Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824. Cancer. 2025. PMID: 40159434 Free PMC article.
115 results